Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Tsutomu Takeuchi, Nobuyuki Miyasaka, Ron D. Pedersen, Noriko Sugiyama & Tomohiro Hirose. (2021) Radiographic and clinical effects of 10 mg and 25 mg twice-weekly etanercept over 52 weeks in Japanese patients with active rheumatoid arthritis. Modern Rheumatology 31:2, pages 319-325.
Read now
Read now
Camilla Brødsgaard Nielsen, Christian Nielsen, Mads Nybo, Søren Andreas Just & Pernille Just Vinholt. (2020) The in vitro effect of antirheumatic drugs on platelet function. Platelets 31:2, pages 248-257.
Read now
Read now
Hisashi Yamanaka, Tomohiro Hirose, Yutaka Endo, Noriko Sugiyama, Yuri Fukuma, Yosuke Morishima, Naonobu Sugiyama, Noritoshi Yoshii, Nobuyuki Miyasaka & Takao Koike. (2019) Three-year safety and two-year effectiveness of etanercept in patients with rheumatoid arthritis in Japan: Results of long-term postmarketing surveillance. Modern Rheumatology 29:5, pages 737-746.
Read now
Read now
Articles from other publishers (12)
Masataka Kuwana, Naonobu Sugiyama, Shigeki Momohara, Tatsuya Atsumi, Syuji Takei, Naoto Tamura, Masayoshi Harigai, Takao Fujii, Hiroaki Matsuno, Tsutomu Takeuchi, Kazuhiko Yamamoto, Yoshinari Takasaki, Miki Tanigawa, Yutaka Endo, Tomohiro Hirose, Yosuke Morishima, Noritoshi Yoshii, Tsuneyo Mimori & Michiaki Takagi. (2023) Six-month safety and effectiveness of tofacitinib in patients with rheumatoid arthritis in Japan: Interim analysis of post-marketing surveillance. Modern Rheumatology.
Crossref
Crossref
Takuo Ogihara, Kenta Mizoi & Akiko Ishii-Watabe. (2023) Pharmacokinetics of Biopharmaceuticals: Their Critical Role in Molecular Design. Biomedicines 11:5, pages 1456.
Crossref
Crossref
Sho Masui, Atsushi Yonezawa, Kotoko Yokoyama, Noriko Iwamoto, Takashi Shimada, Akira Onishi, Hideo Onizawa, Takayuki Fujii, Kosaku Murakami, Koichi Murata, Masao Tanaka, Shunsaku Nakagawa, Daiki Hira, Kotaro Itohara, Satoshi Imai, Takayuki Nakagawa, Makoto Hayakari, Shuichi Matsuda, Akio Morinobu, Tomohiro Terada & Kazuo Matsubara. (2022) N-terminus of Etanercept is Proteolytically Processed by Dipeptidyl Peptidase-4. Pharmaceutical Research 39:10, pages 2541-2554.
Crossref
Crossref
Sawa Miyagawa, Tadashi Miyamoto & Yukihito Sato. (2020) Soluble tumour necrosis factor-alpha receptor improved the function, hypertrophy, and granular sparkling appearance of the left ventricular myocardium in systemic amyloid A amyloidosis: a case report. European Heart Journal - Case Reports 4:3, pages 1-7.
Crossref
Crossref
V. Rzepecki, J. Reynes, V. Le Moing, P. Braquet, V. Faucherre, L. Lohan, D. Morquin & A. Makinson. (2019) Severe HIV-associated aphthous stomatitis treated with etanercept. Médecine et Maladies Infectieuses 49:3, pages 219-220.
Crossref
Crossref
Jae-Chul Lee, Chan Woo Park, Myoung Cheol Shin, Jun Hwi Cho, Hyang-Ah Lee, Young-Myeong Kim, Joon Ha Park, Ji Hyeon Ahn, Jeong Hwi Cho, Hyun-Jin Tae, In Koo Hwang, Tae-Kyeong Lee, Moo-Ho Won & Il Jun Kang. (2018) Tumor necrosis factor receptor 2 is required for ischemic preconditioning-mediated neuroprotection in the hippocampus following a subsequent longer transient cerebral ischemia. Neurochemistry International 118, pages 292-303.
Crossref
Crossref
Kazuhiko HarutaNatsuki OtakiMasakazu NagamineTomoyoshi KayoAsako SasakiShinsuke HiramotoMasayuki TakahashiKuniyoshi HotaHideaki SatoHiroaki Yamazaki. (2017) A Novel PEGylation Method for Improving the Pharmacokinetic Properties of Anti-Interleukin-17A RNA Aptamers. Nucleic Acid Therapeutics 27:1, pages 36-44.
Crossref
Crossref
Hisashi Yamanaka, Yoshiya Tanaka, Tsutomu Takeuchi, Naonobu Sugiyama, Hirotoshi Yuasa, Shigeyuki Toyoizumi, Yosuke Morishima, Tomohiro Hirose & Samuel Zwillich. (2016) Tofacitinib, an oral Janus kinase inhibitor, as monotherapy or with background methotrexate, in Japanese patients with rheumatoid arthritis: an open-label, long-term extension study. Arthritis Research & Therapy 18:1.
Crossref
Crossref
Kunihiro Yamaoka. (2016) Benefit and Risk of Tofacitinib in the Treatment of Rheumatoid Arthritis: A Focus on Herpes Zoster. Drug Safety 39:9, pages 823-840.
Crossref
Crossref
Hideji HANABUSA, Midori SHIMA, Keiji NOGAMI, Tadashi MATSUSHITA, Katsuyuki FUKUTAKE, Masashi TAKI, Michio SAKAI, Yingwen DONG, Srividya NEELAKANTAN, Lynda M. CRISTIANO, Glenn F. PIERCE & Baisong MEI. (2016) Evaluation of the safety, pharmacokinetics, and efficacy of recombinant factor VIII fc fusion protein in Japanese subjects with severe haemophilia A: analysis from the A-LONG study. Japanese Journal of Thrombosis and Hemostasis 27:6, pages 665-677.
Crossref
Crossref
Midori SHIMA, Katsuyuki FUKUTAKE, Hideji HANABUSA, Tadashi MATSUSHITA, Masashi TAKI, Michio SAKAI, Toshiyuki HIRAKATAYingwen DONG, Shuanglian LI, Lynda M. CRISTIANO, Glenn F. PIERCE & Baisong MEI. (2015) Japanese subject subpopulation analysis of B-LONG: a Phase 3 study of long-acting recombinant factor IX Fc fusion protein. Japanese Journal of Thrombosis and Hemostasis 26:4, pages 420-429.
Crossref
Crossref
Naohiro Iwata, Hiroko Takayama, Meiyan Xuan, Shinya Kamiuchi, Hirokazu Matsuzaki, Mari Okazaki & Yasuhide Hibino. (2015) Effects of Etanercept against Transient Cerebral Ischemia in Diabetic Rats. BioMed Research International 2015, pages 1-10.
Crossref
Crossref